Miranda Broz, PhD, scientific director, Discovery Myeloid Biology, Tumor Microenvironment Thematic Research Center, is committed to making positive change at every scale — from her work at Bristol Myers Squibb interrogating microscopic cells in the human body, to her volunteer work reshaping and empowering communities a continent away. Miranda has been passionate about helping others for as long as she can remember — it’s a part of her DNA.

Growing up, Miranda’s grandparents lived with her, and her grandfather, who was paraplegic after suffering a stroke, was taken care of by her grandmother. Being surrounded by medicine inspired Miranda to devote her life to making a difference in the lives of others.  

Miranda works alongside other women in R&D who are making a difference and contributing to science. 

Victoria Diab is a bone marrow transplant nurse by training and has throughout her career cared for adults with hematologic malignancies. Since joining the CAR T Speakers Bureau at Bristol Myers Squibb in 2021, Victoria has played a vital role in elevating awareness and advocating for policies that support medical innovation and patient access to medicines by engaging with policymakers at every level of government. This work includes state and federal virtual “fly-in” events hosted by PhRMA to educate them, with the goal of improving patient access to innovative therapies for those who could benefit from them. Her thoughtful approach when educating policymakers about CAR T and advocating for medical innovation, research and patient access, earned her the PhRMA Working for Cures Champion award.

Our patient-centric culture is instilled in our leaders, and our employees are personally and professionally invested in developing life changing medicines for patients.  

Mentorship is an important part of the culture at Bristol Myers Squibb, and supports our competitive advantage as a diverse, inclusive workforce and leaders are encouraged to cultivate and support female employees and executives through targeted development, coaching, mentoring and sponsorship programs. 

Many leaders like Amy pursue mentorship opportunities through roles within our People and Business Resource Groups (PBRGs), which help us sustain a culture of inclusion that relies on the diversity of our people and our unique perspectives to achieve our patient-focused mission and objectives.

Amy is active in the company’s Bay Area chapter of B-NOW, the Bristol Myers Squibb Network of Women. B-NOW drives business performance by embracing gender diversity, ensuring that all women at Bristol Myers Squibb have equal opportunities to develop, advance and be retained globally within a culture that prioritizes this mission.

“My fellow colleagues not only exemplify the scientific excellence, patient centricity, and inclusive culture driven by Bristol Myers Squibb’s core values, but they proactively work to mentor and instill these qualities in their team members as well as the next generation of STEM professionals,” said Amy.

Amy’s leadership has been recognized internally and externally across the industry, including in 2022 being named a recipient of the James B.D. Palmer Award for Excellence in Drug Development at Bristol Myers Squibb, a recipient of the San Francisco Business Times’ Most Influential Women in Business award, an awardee of the Top 25 Healthcare Technology Leaders of San Francisco, and in 2020 as a founding member of the San Francisco CHIEF chapter, a networking organization specifically focused on connecting and supporting women leaders across industries.

The impact of women-led R&D

Each of these women plays an integral role in fostering our culture of inclusion and diversity and help propel their teams and colleagues into groundbreaking research.

Our leaders’ dedication to embracing diversity and fostering an environment where we can all work together at our full potential propels our mission to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.